Stock Comparison
ABBV vs NVO
AbbVie Inc and Novo Nordisk A/S side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$439.97B
$204.55B
P/E (TTM)
70.3
11.4
Forward P/E
17.7
13.5
Price/Sales
6.8
0.6
Price/Book
51.1
6.0
EV/EBITDA
25.8
8.2
Dividend Yield
2.03%
3.86%
Profitability
Net Margin
9.82%
37.20%
Operating Margin
29.77%
45.30%
Return on Equity
62.30%
59.80%
Return on Assets
10.50%
18.70%
Growth (YoY)
Revenue Growth
10.20%
2.10%
Earnings Growth
290.40%
-20.60%
Price & Risk
Beta
0.3
0.3
52-Week High
$263.65
$61.85
52-Week Low
$197.38
$34.84
Analyst Target
$274.36
$47.32
Compare ABBV and NVO your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.